MANAGEMENT DEVICE AND MANAGEMENT METHOD
    11.
    发明申请
    MANAGEMENT DEVICE AND MANAGEMENT METHOD 失效
    管理设备和管理方法

    公开(公告)号:US20120324192A1

    公开(公告)日:2012-12-20

    申请号:US13589252

    申请日:2012-08-20

    CPC classification number: G06F3/0647 G06F3/0605 G06F3/067 G06F2206/1008

    Abstract: A management device and management method capable of improving usability of a storage system is proposed. The management device and the management method for managing data migration between volumes in a storage system in which normal volumes to which fixed storage areas are allocated in advance and virtual volumes to which storage areas are dynamically allocated according to use status coexist as types of volumes for reading and writing data is arranged so that information regarding each volume is collected, and based on the collected information, at least a total logical capacity that is a summation of logical capacities determined in advance for the respective volume is separately displayed for normal volumes and virtual volumes.

    Abstract translation: 提出了一种能够提高存储系统的可用性的管理装置和管理方法。 用于管理存储系统中的卷之间的数据迁移的管理装置和管理方法,其中预先分配固定存储区域的正常卷和根据使用状态动态分配存储区域的虚拟卷共存为卷的类型 读取和写入数据被布置成使得关于每个卷的信息被收集,并且基于收集的信息,对于正常的卷和虚拟的,分别显示作为对于各个卷预先确定的逻辑容量的总和的总逻辑容量的总和逻辑容量 卷。

    MANAGEMENT DEVICE AND MANAGEMENT METHOD
    12.
    发明申请
    MANAGEMENT DEVICE AND MANAGEMENT METHOD 有权
    管理设备和管理方法

    公开(公告)号:US20080270720A1

    公开(公告)日:2008-10-30

    申请号:US11968253

    申请日:2008-01-02

    CPC classification number: G06F3/0647 G06F3/0605 G06F3/067 G06F2206/1008

    Abstract: A management device and management method capable of improving usability of a storage system is proposed. The management device and the management method for managing data migration between volumes in a storage system in which normal volumes to which fixed storage areas are allocated in advance and virtual volumes to which storage areas are dynamically allocated according to use status coexist as types of volumes for reading and writing data is arranged so that information regarding each volume is collected, and based on the collected information, at least a total logical capacity that is a summation of logical capacities determined in advance for the respective volume is separately displayed for normal volumes and virtual volumes.

    Abstract translation: 提出了一种能够提高存储系统的可用性的管理装置和管理方法。 用于管理存储系统中的卷之间的数据迁移的管理装置和管理方法,其中预先分配固定存储区域的正常卷和根据使用状态动态分配存储区域的虚拟卷共存为卷的类型 读取和写入数据被布置成使得关于每个卷的信息被收集,并且基于收集的信息,对于正常的卷和虚拟的,分别显示作为对于各个卷预先确定的逻辑容量的总和的总逻辑容量的总和逻辑容量 卷。

    Tetrahydrobenzindolone derivatives
    13.
    发明授权
    Tetrahydrobenzindolone derivatives 有权
    四氢苯并吲哚酮衍生物

    公开(公告)号:US6077840A

    公开(公告)日:2000-06-20

    申请号:US331294

    申请日:1999-06-18

    Abstract: Compounds represented by the following formula (I) or pharmaceutically acceptable salts thereof and a process for producing the same are disclosed. The compounds have progesterone receptor binding inhibitory activity and, hence, can be used as therapeutic and prophylactic agents for progesterone-related diseases. Specifically, they are useful as carcinostatic agents for breast cancer and ovarian cancer, therapeutic agents for hysteromyoma, endometriosis, meningioma, and myeloma, abortifacients, oral contraceptive pills, and therapeutic and prophylactic agents for osteoporosis and climacteric disturbance. ##STR1## wherein R.sup.1 represents alkyl or aralkyl; R.sup.2 represents a hydrogen atom, alkylcarbonyl, cycloalkylcarbonyl, aromatic acyl, heteroaromatic acyl, saturated heterocyclic acyl, alkyl, alkenyl, aralkyl, carbamoyl, alkylcarbamoyl, aromatic carbamoyl, aralkylcarbamoyl, alkylaminocarbonyl, cycloalkylcarbamoyl, alkoxycarbonyl, aryloxycarbonyl, heteroaromatic thiocarbonyl, saturated heterocyclic thiocarbonyl, or alkyl-thiocarbamoyl: and R.sup.3 represents a hydrogen atom, a hydroxyl group, alkyloxy, alkylcarbonyloxy, alkylthio, or arylthio.

    Abstract translation: PCT No.PCT / JP97 / 04683 Sec。 371日期:1999年6月18日 102(e)1999年6月18日PCT 1997年12月18日PCT公布。 第WO98 / 27059号公报 日期:1998年6月25日公开了由下式(I)表示的化合物或其药学上可接受的盐及其制备方法。 所述化合物具有孕酮受体结合抑制活性,因此可用作孕酮相关疾病的治疗和预防剂。 具体地说,它们可用作乳腺癌和卵巢癌的制癌剂,子宫肌瘤,子宫内膜异位症,脑膜瘤和骨髓瘤的治疗剂,流产者,口服避孕药以及用于骨质疏松和更年期障碍的治疗和预防剂。 其中R1表示烷基或芳烷基; R 2表示氢原子,烷基羰基,环烷基羰基,芳香族酰基,杂芳基酰基,饱和杂环酰基,烷基,烯基,芳烷基,氨基甲酰基,烷基氨基甲酰基,芳香族氨基甲酰基,芳烷基氨基甲酰基,烷基氨基羰基,环烷基氨基甲酰基,烷氧基羰基,芳氧基羰基,杂芳硫基羰基,饱和杂环硫代羰基, 或烷基 - 硫代氨基甲酰基:和R3表示氢原子,羟基,烷氧基,烷基羰氧基,烷硫基或芳硫基。

Patent Agency Ranking